Skip to content

The application of volume-based respiratory training device in the perioperative period of elderly colorectal tumor patients

The application of volume-based respiratory training device in the perioperative period of elderly colorectal tumor patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111497
Enrollment
Unknown
Registered
2025-10-31
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumor

Interventions

Experimental group:Volume-based respiratory training device
Control group:Routine respiratory training

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for colorectal tumor surgery; 2.80>age>=60 years; 3.No pulmonary infection or other pulmonary complications appeared;

Exclusion criteria

Exclusion criteria: 1.Patients with inspiratory muscle fatigue, severe impairment of respiratory muscle function, unstable vital signs, delirium, confusion, severe malnutritionsuch as hypoproteinemia, serum albumin (<25g/L), cachexia, pneumothorax, pulmonary bullae, pulmonaryema, recent myocardial infarction or unstable angina, moderate-severe hepatic insufficiency, recent facial-oral-cranial base surgery trauma, postoperative active bleeding, highly suspected or confirmed anastomotic leakage and hernia, patients after chemotherapy perfusion (especially HIPEC), patients with appendice tumors requiring perfusion, active intra-abdominal infection/abscess, moderate-large amount of pleural effusion and ascites, ascites, intra-abdom adhesions or intestinal obstruction, patients using specific anti-angiogenic targeted drugs (such as bevacizumab), and patients after long-term hormone use .

Design outcomes

Primary

MeasureTime frame
Pulmonary complications;Modified Borg Dyspnea scale;Cough efficacy score;

Secondary

MeasureTime frame
Quality of life;6 minute walk test,6MWT;Hypoxemia complication;Number of days hospitalized;30-day readmission rate after surgery;Blood indicators;

Countries

China

Contacts

Public ContactLiao Xi

West China Hospital of Sichuan University

2379133447@qq.com+86 28 8542 2480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026